BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1906932)

  • 21. Prolactin dynamics in a patient with isolated ACTH deficiency accompanied by hyperprolactinemia.
    Shibutani Y
    Am J Med Sci; 1988 Feb; 295(2):140-3. PubMed ID: 2830786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin and thyroid-stimulating hormone responses to thyrotropin-releasing hormone in cases of hyperprolactinemia with normal and abnormal sella tomograms.
    Badawy SZ; Moses A; Streeten D; Marshall L; Marlin D; Notman D
    Int J Fertil; 1983; 28(4):213-8. PubMed ID: 6142012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of prolactin secretion.
    Benker G; Jaspers C; Häusler G; Reinwein D
    Klin Wochenschr; 1990 Dec; 68(23):1157-67. PubMed ID: 2126309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine.
    Boulanger CM; Mashchak CA; Chang RJ
    Fertil Steril; 1985 Oct; 44(4):532-5. PubMed ID: 4054327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Hypothyroidism with Exceptionally High Prolactin-A Really Big Deal.
    Khorassanizadeh R; Sundaresh V; Levine SN
    World Neurosurg; 2016 Jul; 91():675.e11-4. PubMed ID: 27155380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
    Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A
    Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperprolactinemia: etiology, diagnosis, and management.
    Mah PM; Webster J
    Semin Reprod Med; 2002 Nov; 20(4):365-74. PubMed ID: 12536359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolactin secretion is increased in patients with multiple sclerosis.
    Azar ST; Yamout B
    Endocr Res; 1999 May; 25(2):207-14. PubMed ID: 10382682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
    Shah GV; Shyr SW; Grosvenor CE; Crowley WR
    Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Galactorrhea-amenorrhea syndrome: diagnosis and therapy.
    Boyd AE; Reichlin S; Turksoy RN
    Ann Intern Med; 1977 Aug; 87(2):165-75. PubMed ID: 407824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A neuroendocrinological investigation of patients with senile demantia of Alzheimer type. Plasma prolactin and GH responses following TRH, sulpiride, L-dopa, and bromocriptine administration.
    Fujita M; Shimizu T
    Bull Osaka Med Sch; 1986 Oct; 32(2):73-84. PubMed ID: 3122863
    [No Abstract]   [Full Text] [Related]  

  • 32. Autonomous hyperprolactinemia in tuberous sclerosis.
    Bloomgarden ZT; McLean GW; Rabin D
    Arch Intern Med; 1981 Oct; 141(11):1513-5. PubMed ID: 7197143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of calcium channel blockade with verapamil on the prolactin responses to TRH, L-dopa, and bromocriptine.
    Kamal TJ; Molitch ME
    Am J Med Sci; 1992 Nov; 304(5):289-93. PubMed ID: 1332473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time Course of Resolution of Hyperprolactinemia After Transsphenoidal Surgery Among Patients Presenting with Pituitary Stalk Compression.
    Zaidi HA; Cote DJ; Castlen JP; Burke WT; Liu YH; Smith TR; Laws ER
    World Neurosurg; 2017 Jan; 97():2-7. PubMed ID: 27671881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Perić LA
    J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galactorrhea in a 14-year-old girl.
    Panamonta O; Pakawut N
    J Med Assoc Thai; 2006 Aug; 89(8):1304-7. PubMed ID: 17048445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolactin response to thyrotropin-releasing hormone in normoprolactinemic patients with ovulatory dysfunction and its use for selection of candidates for bromocriptine therapy.
    Steinberger E; Nader S; Rodriguez-Rigau L; Ayala C; Smith K
    J Endocrinol Invest; 1990 Sep; 13(8):637-42. PubMed ID: 2148756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A study on pathogenesis and treatment of normoprolactinemic galactorrhea syndrome].
    Aisaka K; Ando S; Kokubo K; Sasaki S; Sudo I; Toriya Y; Yoshida K; Mori H
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2385-92. PubMed ID: 4078422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiopathic hyperprolactinemia in a 15-year-old boy: a case report and literature review.
    Jaruratanasirikul S; Janejindamai S
    J Med Assoc Thai; 1995 Jul; 78(7):388-92. PubMed ID: 7658185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperprolactinemia. Long-term effects of bromocriptine.
    Johnston DG; Prescott RW; Kendall-Taylor P; Hall K; Crombie AL; Hall R; McGregor A; Watson MJ; Cook DB
    Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.